vs
Side-by-side financial comparison of BALCHEM CORP (BCPC) and PARK NATIONAL CORP (PRK). Click either name above to swap in a different company.
BALCHEM CORP is the larger business by last-quarter revenue ($263.6M vs $168.3M, roughly 1.6× PARK NATIONAL CORP). PARK NATIONAL CORP runs the higher net margin — 25.3% vs 14.9%, a 10.5% gap on every dollar of revenue. On growth, BALCHEM CORP posted the faster year-over-year revenue change (9.8% vs 2.2%). Over the past eight quarters, PARK NATIONAL CORP's revenue compounded faster (4.9% CAGR vs 4.9%).
Balchem Corp is a global specialty chemicals and nutritional ingredients provider that develops, manufactures and distributes application-specific products for human nutrition, animal health, pharmaceutical and industrial end markets, serving customers across North America, Europe and Asia Pacific.
National Retail Systems, Inc. (NRS) includes Keystone Freight Corp. & National Retail Transportation, Inc. (NRT). NRS is an asset based 3PL founded in 1952. It is headquartered in Lyndhurst, New Jersey, United States.
BCPC vs PRK — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $263.6M | $168.3M |
| Net Profit | $39.2M | $42.6M |
| Gross Margin | 35.6% | — |
| Operating Margin | 19.8% | — |
| Net Margin | 14.9% | 25.3% |
| Revenue YoY | 9.8% | 2.2% |
| Net Profit YoY | 16.8% | 10.4% |
| EPS (diluted) | $1.21 | $2.62 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $263.6M | $168.3M | ||
| Q3 25 | $267.6M | $169.5M | ||
| Q2 25 | $255.5M | $168.7M | ||
| Q1 25 | $250.5M | $157.9M | ||
| Q4 24 | $240.0M | $164.7M | ||
| Q3 24 | $239.9M | $170.3M | ||
| Q2 24 | $234.1M | $157.7M | ||
| Q1 24 | $239.7M | $152.8M |
| Q4 25 | $39.2M | $42.6M | ||
| Q3 25 | $40.3M | $47.2M | ||
| Q2 25 | $38.3M | $48.1M | ||
| Q1 25 | $37.1M | $42.2M | ||
| Q4 24 | $33.6M | $38.6M | ||
| Q3 24 | $33.8M | $38.2M | ||
| Q2 24 | $32.1M | $39.4M | ||
| Q1 24 | $29.0M | $35.2M |
| Q4 25 | 35.6% | — | ||
| Q3 25 | 35.7% | — | ||
| Q2 25 | 36.4% | — | ||
| Q1 25 | 35.2% | — | ||
| Q4 24 | 36.0% | — | ||
| Q3 24 | 35.6% | — | ||
| Q2 24 | 35.5% | — | ||
| Q1 24 | 34.0% | — |
| Q4 25 | 19.8% | — | ||
| Q3 25 | 20.4% | 34.3% | ||
| Q2 25 | 20.1% | 35.2% | ||
| Q1 25 | 20.4% | 32.4% | ||
| Q4 24 | 19.8% | — | ||
| Q3 24 | 20.0% | 27.4% | ||
| Q2 24 | 19.6% | 30.6% | ||
| Q1 24 | 17.4% | 27.8% |
| Q4 25 | 14.9% | 25.3% | ||
| Q3 25 | 15.1% | 27.8% | ||
| Q2 25 | 15.0% | 28.5% | ||
| Q1 25 | 14.8% | 26.7% | ||
| Q4 24 | 14.0% | 23.5% | ||
| Q3 24 | 14.1% | 22.4% | ||
| Q2 24 | 13.7% | 25.0% | ||
| Q1 24 | 12.1% | 23.0% |
| Q4 25 | $1.21 | $2.62 | ||
| Q3 25 | $1.24 | $2.92 | ||
| Q2 25 | $1.17 | $2.97 | ||
| Q1 25 | $1.13 | $2.60 | ||
| Q4 24 | $1.03 | $2.38 | ||
| Q3 24 | $1.03 | $2.35 | ||
| Q2 24 | $0.98 | $2.42 | ||
| Q1 24 | $0.89 | $2.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $74.6M | $233.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.3B | $1.4B |
| Total Assets | $1.7B | $9.8B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $74.6M | $233.5M | ||
| Q3 25 | $65.1M | $218.9M | ||
| Q2 25 | $65.4M | $193.1M | ||
| Q1 25 | $49.9M | $237.6M | ||
| Q4 24 | $49.5M | $160.6M | ||
| Q3 24 | $73.7M | $201.7M | ||
| Q2 24 | $63.7M | $261.5M | ||
| Q1 24 | $60.3M | $306.1M |
| Q4 25 | $1.3B | $1.4B | ||
| Q3 25 | $1.3B | $1.3B | ||
| Q2 25 | $1.3B | $1.3B | ||
| Q1 25 | $1.2B | $1.3B | ||
| Q4 24 | $1.1B | $1.2B | ||
| Q3 24 | $1.2B | $1.2B | ||
| Q2 24 | $1.1B | $1.2B | ||
| Q1 24 | $1.1B | $1.2B |
| Q4 25 | $1.7B | $9.8B | ||
| Q3 25 | $1.7B | $9.9B | ||
| Q2 25 | $1.7B | $9.9B | ||
| Q1 25 | $1.6B | $9.9B | ||
| Q4 24 | $1.6B | $9.8B | ||
| Q3 24 | $1.6B | $9.9B | ||
| Q2 24 | $1.6B | $9.9B | ||
| Q1 24 | $1.6B | $9.9B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $67.3M | $198.3M |
| Free Cash FlowOCF − Capex | — | $191.9M |
| FCF MarginFCF / Revenue | — | 114.1% |
| Capex IntensityCapex / Revenue | — | 3.8% |
| Cash ConversionOCF / Net Profit | 1.72× | 4.65× |
| TTM Free Cash FlowTrailing 4 quarters | — | $328.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $67.3M | $198.3M | ||
| Q3 25 | $65.6M | $52.6M | ||
| Q2 25 | $47.3M | $49.7M | ||
| Q1 25 | $36.5M | $37.9M | ||
| Q4 24 | $52.3M | $178.8M | ||
| Q3 24 | $51.3M | $43.8M | ||
| Q2 24 | $45.0M | $50.9M | ||
| Q1 24 | $33.4M | $35.0M |
| Q4 25 | — | $191.9M | ||
| Q3 25 | — | $51.1M | ||
| Q2 25 | — | $48.4M | ||
| Q1 25 | — | $36.8M | ||
| Q4 24 | — | $169.7M | ||
| Q3 24 | — | $41.7M | ||
| Q2 24 | — | $49.0M | ||
| Q1 24 | — | $31.9M |
| Q4 25 | — | 114.1% | ||
| Q3 25 | — | 30.1% | ||
| Q2 25 | — | 28.7% | ||
| Q1 25 | — | 23.3% | ||
| Q4 24 | — | 103.0% | ||
| Q3 24 | — | 24.5% | ||
| Q2 24 | — | 31.1% | ||
| Q1 24 | — | 20.8% |
| Q4 25 | — | 3.8% | ||
| Q3 25 | — | 0.9% | ||
| Q2 25 | — | 0.8% | ||
| Q1 25 | — | 0.7% | ||
| Q4 24 | — | 5.6% | ||
| Q3 24 | — | 1.2% | ||
| Q2 24 | — | 1.2% | ||
| Q1 24 | — | 2.1% |
| Q4 25 | 1.72× | 4.65× | ||
| Q3 25 | 1.63× | 1.11× | ||
| Q2 25 | 1.23× | 1.03× | ||
| Q1 25 | 0.98× | 0.90× | ||
| Q4 24 | 1.56× | 4.63× | ||
| Q3 24 | 1.52× | 1.14× | ||
| Q2 24 | 1.40× | 1.29× | ||
| Q1 24 | 1.15× | 0.99× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BCPC
| Human Nutrition And Health | $166.1M | 63% |
| Animal Nutrition And Health | $61.2M | 23% |
| Specialty Products | $34.8M | 13% |
PRK
Segment breakdown not available.
